Fig. 6 | Nature Communications

Fig. 6

From: Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism

Fig. 6The alternative text for this image may have been generated using AI.

Conjugated BAs inhibited the FXR-FGF15 to induce hepatic BA synthesis. a Gene expression of FXR and FGF15 in ileum of mice fed HFD and 450 mg/Kg/day Pu-erh tea for 26 weeks. n = 8 individuals/group. b FXR and FGF15 protein expression level in ileum of mice fed HFD and 450 mg/Kg/day Pu-erh tea for 26 weeks. n = 3 individuals/group. c Gene expression of FXR and FGF15 in ileum of mice fed HFD and 225 mg/Kg/day theabrownin for 8 weeks. n = 8 individuals/group. d Serum FGF15 levels of mice fed HFD and 450 mg/Kg/day Pu-erh tea for 26 weeks. n = 8 individuals/group. e Serum FGF19 levels of human subjects that received standard diet and 50 mg/Kg/day Pu-erh tea for 4 weeks. n = 13 individuals/group. f Hepatic mRNA expression levels of BA synthetic enzymes of mice fed HFD and 450 mg/Kg/day Pu-erh tea for 26 weeks. n = 8 individuals/group. g Hepatic mRNA expression levels of BA synthetic enzymes of mice fed HFD and 225 mg/Kg/day theabrownin for 8 weeks. n = 8 individuals/group. h Hepatic protein expression levels of BA synthetic enzymes of mice fed HFD and 450 mg/Kg/day Pu-erh tea for 26 weeks. n = 3 individuals/group. i IHC staining of hepatic BA synthetic proteins of mice fed HFD and 450 mg/Kg/day Pu-erh tea for 26 weeks (scale bar, 50 μm). The mRNA expression and protein expression were normalized to GAPDH and β-Actin, respectively. Data were expressed as mean ± SEM. Differences between data in mice and human were assessed by Mann–Whitney U test and Wilcoxon rank-sum test, respectively, *p < 0.05, #p < 0.005

Back to article page